Earlybird Health names two new partners to strengthen its focus on biotech and data-driven healthcare

Earlybird Health is part of Earlybird Venture Capital and focuses on early-stage investments in biotech, medtech, and digital health. The larger Earlybird group manages over €2.5 billion in assets and has supported more than 70 companies across Europe, including nine IPOs and 36 acquisitions.

“Rabab and Chris combine discipline and bold thinking. As they step into the partnership, they will help lead the future of Earlybird Health,”

said Thom Rasche, Partner at Earlybird Health.

“They have each helped shape how we evaluate opportunities, support portfolio teams, and translate innovation into clinical impact.”

Christoph Massner joined Earlybird in 2018 and brings a strong commercial perspective across diagnostics, healthtech platforms, and device-based therapeutics. He has led several deals under Earlybird Health I & II, focusing on business models that use data and AI to improve healthcare delivery and product development.

Read Also - Marleybones raises £2.5M to expand its Pantry Fresh® dog food range

He serves on the boards of Noscendo, Ariceum Therapeutics, and Hilo, and is a board observer at Shape Memory Medical and Alesi Surgical. Earlybird noted that he also helps connect its health investments with the broader technology ecosystem.

Rabab Nasrallah, who joined Earlybird in 2020, brings a strong focus on therapeutics and platform-based investments. She has helped shape the firm’s biotech strategy and build partnerships with venture and pharmaceutical investors across Europe and the U.S.

Her board roles include HAYA Therapeutics, Greywolf Therapeutics, and Portal Biotech, along with observer positions at GEMMABio, Priothera, ImCheck Therapeutics, and Prothea Technologies.

These promotions highlight Earlybird Health’s growing influence in Europe’s life sciences sector, which continues to attract strong investor interest. In 2024, European life sciences venture funding surpassed €10 billion, driven by rapid progress in precision medicine, AI-powered drug discovery, and clinical technologies.

Earlybird Health

Earlybird Health is a Pan-European venture capital firm that invests in early-stage healthcare innovations. It supports startups working in digital health, biopharma, medical devices, diagnostics, and R&D tools — all aimed at improving patient outcomes. As part of the larger Earlybird Venture Capital group, founded in 1997, Earlybird Health focuses on helping European health tech companies grow by providing funding, strategic guidance, and access to a global network to support their development and commercialization.